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(MMPs) which degrade the cartilage matrix. Of the cytokines implicated
in the pathophysiology of OA, IL-1 has attracted the most interest as a
target for disease modiﬁcation and IL-1 inhibition has been reported to
be beneﬁcial in several animal models of OA. In considering potential
barriers that may limit the use of biological therapeutics in treating
cartilage-associated diseases, we asked whether two IL-1 receptor
antagonists were capable of penetrating cartilage and reaching the IL-1
receptor on chondrocytes. In the present study we evaluate the efﬁcacy
of IL-1ra (Kineret; ~17 kDa) and a monoclonal IL-1R antibody (6F3;
~150 kDa)) as antagonists of IL-1 in human chondrocytes and cartilage
explants from non-arthritic donors.
Methods: Human primary chondrocytes and cartilage explants (3-
mm diameter) were obtained from Articular Engineering (Chicago, IL).
Chondrocytes and cartilage explants were incubated with Kineret or
6F3 for 30 min prior to stimulation with 1ng/ml IL-1b. MMP-13 levels
in the conditioned media were measured using an MMP-13 Fluorokine
Assay (R&D Systems). Detection of endogenous antibodies in the joints
of rat, wild-type mice or mice expressing human immunoglobulins was
assessed by immunohistochemistry using secondary anti-rat, anti-mouse
or anti-human antibodies.
Results: In human primary chondrocyte cultures, both Kineret and 6F3
were potent inhibitors of IL-1 induced MMP-13 production. Whereas
Kineret retained its potency in cartilage explants, the potency of 6F3 was
dramatically diminished in cartilage explants, suggesting that the larger
molecule was impaired from reaching its target by the extracellular
matrix. To further address whether antibodies penetrate cartilage, the
detection of endogenous antibodies in the joints of rat, wild-type
mice or mice expressing human immunoglobulins was assessed by
immunohistochemistry using secondary anti-rat, anti-mouse or anti-
human antibodies. Endogenous rat, mouse or human antibodies were
not present in either articular or growth plate cartilage. In contrast,
saturating levels of endogenous antibody was detected in the adjacent
ﬁbrocartilage and soft tissues including the synovium, ligaments, the
joint capsule and stroma surrounding bone marrow blood vessels.
Conclusions: Collectively, these data demonstrate that antibodies do
not normally penetrate either articular or growth plate cartilage. As
such, antibodies do not represent a viable therapeutic modality for
targeting chondrocyte-mediated processes. Smaller alternatives such as
Fab′ fragments and non-antibody scaffolds may offer advantages over
antibodies for achieving cartilage penetration.
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TROPHIC EFFECTS OF MESENCHYMAL STEM CELLS INCREASE
CHONDROCYTE PROLIFERATION AND MATRIX FORMATION
L. Wu, J. Leijten, N. Georgi, C.A. van Blitterswijk, M. Karperien. Univ. of
Twente, Enschede, Netherlands
Purpose: Previous studies have shown that co-culture of primary
chondrocytes with various sources of multipotent cells results in a higher
relative amount of cartilage matrix formation than cultures containing
only chondrocytes. The aim of this study is to investigate the mechanism
underlying this observation.
Methods: Cell culture: Human primary chondrocytes (PC) were isolated
from cartilage biopsies of patients undergoing total knee replacement
after collagenase II digestion. Human mesenchymal stem cells were
isolated from bone marrow aspirates. The use of all human biopsies
in this study was approved by a local Medical Ethical Committee.
Histology: Cell pellets were ﬁxed and embedded in parafﬁn
using routine procedures. Sections were cut and stained for
sulfated glycosaminoglycans (GAG) with alcian blue combined with
counterstaining of nuclear fast red.
GAG and DNA assay: Cell pellets were were digested with proteinase K to
release GAGs. Then GAG content was spectrophotometrically determined
with 1,9-dimethylmethylene blue chloride using an ELISA reader. Cell
number was determined by quantiﬁcation of total DNA using a CyQuant
DNA Kit.
EdU staining and quantiﬁcation: EdU (5-ethynyl-2′-deoxyuridine) was
added to the culture media to label proliferating cells. Pellets were
cryosectioned and stained for EdU with Click-iT® EdU Imaging Kit.
Nuclei were counterstained with Hoechst 33342. Images were taken
and analyzed with ImageJ.
Short Tandem Repeats (STR) analysis. STR analyses of genomic DNA
samples were performed with PowerPlex 16 System. The amount of
DNA present for each donor was calculated from the areas of the
electropherogram for each locus of MSCs’ or PCs’ speciﬁc alleles and
the ratio of MSCs and PCs was determined.
Results: Cocultures increase GAG formation. Histology and GAG
quantiﬁcation were performed to evaluate cartilage formation. Alcian
blue staining indicated the presence of GAG in all experimental
groups. In the positively stained areas, cells showed typical chondrocyte
morphology and embedding in lacunae. GAG quantiﬁcation showed a
trend of increasing total GAG with increasing initial percentage of PC.
When total GAG content was normalized to the initial percentage of
PC, co-culture pellets showed signiﬁcantly higher GAG content than
monocultures.
Cocultures increase chondrocytes proliferation. Cell proliferation was
then examined by using EdU incorporation. PCs were labeled with CM-
DiI to distinguish them from MSCs. At day 2, EdU positive cells were
predominantly found at the periphery of the pellets where red labeled
PCs resided. The percentage of EdU positive MSCs or PC was determined.
PCs in cocultures proliferate at higher rate than PC in monocutlure.
Ratio of MSCs decreases after coculture. To determine the ratio of MSC
and PC after coculture STR loci in different donors were analyzed. The
results indicated that the proportion of MSCs decreased signiﬁcantly
after 4 weeks cocultures.
Conclusions: In pellet cocultures, MSC act as trophic mediators
stimulating cartilage matrix formation by promoting proliferation of
primary chondrocytes rather than differentiating into chondrocytes.
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THROMBIN AND PLASMIN ARE ABLE TO INDUCE PROTEOGLYCAN
RELEASE IN A PAR-INDEPENDENT MANNER IN HUMAN CARTILAGE
L. Nieuwenhuizen1,2, R.E. Schutgens2, G. Roosendaal2, D.H. Biesma2,
S. Mastbergen1, F.P. Lafeber1. 1Rheumatology & Clinical Immunology, Univ.
Med. Ctr. Utrecht, Utrecht, Netherlands; 2Hematology and Van Creveld
Clinic, Univ. Med. Ctr. Utrecht, Utrecht, Netherlands
Purpose: Osteoarthritis (OA) and Rheumatoid Arthrisis (RA) are
characterized by degradation of the cartilage. Proteases of the coagulation
cascade and the ﬁbrinolytic system are elevated in both plasma and
synovial ﬂuid of OA and RA patients. Cross-talking between coagulation
and inﬂammation is mediated by protease-activated-receptors (PARs),
a cell membrane receptor family. These receptors are transmembrane
G protein-coupled receptors that are activated through cleavage by
serine proteases, such as thrombin and plasmin. PARs are expressed at
increased levels in human OA and RA synovium and cartilage. Activation
of these PARs results in the induction of catabolic and proinﬂammatory
pathways. Our aim was to study whether thrombin, plasmin and PAR
agonists induce cartilage damage in human healthy and OA cartilage.
Furthermore, we wanted to investigate if thrombin and plasmin induce
cartilage damage in a PAR-dependent manner.
Methods: Healthy full-thickness human articular cartilage tissue was
obtained postmortem within 24 hours after death of the donor. Full-
thickness OA human articular cartilage tissue was obtained during
total knee surgery. Slices of cartilage were cut aseptically from the
articular surface and kept in phosphate-buffered saline. Within 1 hour
of dissection the slices were cut into square pieces, weighed aseptically
(range, 5.0 to 15.0mg) and each sample was individually put into culture.
Cartilage was pre-cultured for two days in medium supplemented
with serum. Subsequently, the cartilage was cultured in serum-free
medium. After 24h the serum-free medium was refreshed and cartilage
was cultured for 4 days in serum-free medium in the presence of
different concentrations thrombin (10, 30 or 100nM), plasmin (1, 3, 10,
30 or 100nM), PAR1 agonist TFLLR-NH2(100mM), PAR2 agonist SLIGKV
(100mM), with or without co-culture with PAR1 antagonist SCH79797
(100mM) or PAR2 antagonist FSLLRY-NH2 (100mM). Cartilage matrix
turnover, in terms of proteoglycan synthesis, -release, and -content, was
determined at day 4.
Results: Thrombin and plasmin increased proteoglycan release in both
healthy cartilage and osteoarthritis cartilage in a dose-dependent manner
(471% for thrombin at 100nM; 744% for plasmin at 100nM; both
p < 0.05). Proteoglycan synthesis and content were not signiﬁcantly
changed by thrombin or plasmin. Thrombin-induced and plasmin-
induced proteoglycan release were not affected by co-culture with either
PAR1 antagonist SCH79797, or PAR2 antagonist FSLLRY-NH2. Also the
direct stimulation with PAR1 agonist TFLLR-NH2, or PAR2 agonist SLIGKV
failed to induce proteoglycan release.
S106 Poster Presentations / Osteoarthritis and Cartilage 19S1 (2011) S53–S236
Conclusions: Both thrombin and plasmin were able to induce
proteoglycan release in a dose-dependent manner. PAR1 and PAR2
antagonists were not able to inhibit the thrombin- and plasmin induced
proteoglycan release. Furthermore, the PAR agonists TFLLR-NH2 and
SLIGKV failed to induce proteoglycan release. This suggests that both
thrombin and plasmin induce proteoglycan release and that both are
able to damage the human cartilage in a PAR-independent manner.
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STUDY OF THE ASSOCIATION BETWEEN BONE SIALOPROTEIN,
HYPERTROPHIC DIFFERENTIATION OF CHONDROCYTES AND
CARTILAGE LESIONS IN OSTEOARTHRITIC CARTILAGE
L. Pesesse1, C. Sanchez1, D.A. Walsh2, C. Baudouin3, P. Msika3,
Y. Henrotin1. 1Univ. of Lie`ge, Lie`ge, Belgium; 2Univ. of Nottingham,
Nottingham, United Kingdom; 3Lab. ExpanSci., IRD Direction, Epernon,
France
Purpose: Chondrocyte hypertrophy is commonly observed in OA
cartilage, associated with matrix mineralization and vascularization.
In previous work, we demonstrated that hypertrophic differentiation
of chondrocytes is initiated by serum-enriched medium in long-term
culture in alginate beads suggesting a role played by blood supply in the
hypertrophic differentiation of chondrocytes in OA.
This study aims to investigate the production of Bone SialoProtein (BSP),
an angiogenesis enhancer known to promote endothelial cell attachment
and migration, during hypertrophic differentiation of OA chondrocytes
and its expression in OA cartilage according to the severity of the
lesions by immunohistochemistry. This work was supported by an OARSI
scholarship grant.
Methods: Articular OA chondrocytes were cultured for 28 days in alginate
beads in culture medium containing 2% Ultroser G (UG) or 10% Fetal
Bovine Serum (FBS). DNA was quantiﬁed by ﬂuorimetry. The expression
of BSP and hypertrophic differentiation marker COL10A1 was evaluated
by RT-PCR. Alkaline phosphatase (AP) activity and 5′phosphodiesterase
activity of NTPPPH were quantiﬁed by speciﬁc enzymatic methods.
Western Blot analysis was performed from chondrocyte protein extracts
with anti-BSP antibody (LFMb-24).
Human bone and cartilage samples from 9 post-mortem (PM) individuals
and 24 patients undergoing total knee joint replacement for OA
(TKR) were formalin-ﬁxed, EDTA-decalciﬁed and wax embedded. Five
mm tissue sections were cut and stained. Macroscopic chondropathy
score described previously by Walsh et al. and the modiﬁed Mankin
score were respectively used to establish macroscopic and microscopic
chondropathy scores for individual knees. BSP was immunolocalized in
cartilage using anti-BSP monoclonal antibody (LFMb-25) and anti-BSP
polyclonal antibody (ab52128) to conﬁrm the speciﬁcity of staining. A
scoring system was established according to the location of the stained
cells in cartilage (0: no staining – 1: staining in the superﬁcial layer –
2: staining in the middle layer – 3: staining in the deep layer). All
histological scoring was undertaken twice blinded to patient group, using
a Zeiss Axioscop-50 microscope.
Data were analyzed using GraphPad Prism software, version 5.
Associations between variables were reported as Spearman’s rank
correlation coefﬁcients (r).
Results: In alginate beads, chondrocytes cultured in serum-
supplemented medium underwent a hypertrophic differentiation process
characterized by the increased expression of hypertrophic differentiation
markers. In the same manner, the expression of BSP increased in FBS
with long-term culture and was associated with markers of chondrocytes
hypertrophy; COL10A1 (r = 0.67; p =0.005), AP (r = 0.8; p = 0.0002) and
NTPPPH (r = 0.68; p = 0.004). After 21 days, BSP was also detected in
protein extracts of chondrocytes cultured in serum but not in UG.
BSP-immunoreactive chondrocytes were localized at increased depth in
cartilage from OA joints (2.3±0.63) than from PM controls (0.56±0.54),
(p = 0.005). The expression of BSP in patients with OA was associated with
the severity of macroscopic cartilage lesions (r = 0.5; p = 0.01). Highly
signiﬁcant correlations were also observed with the modiﬁed Mankin
score (r = 0.71; p < 0.0001) and with the individual scoring criteria of
cartilage surface integrity (r = 0.51; p =0.01), chondrocyte appearance
(r = 0.44; p =0.03) and proteoglycan loss (r = 0.61; p =0.001).
Conclusions: Genetic and protein expression of BSP are associated with
hypertrophic differentiation of chondrocytes in OA. Location of BSP in
OA cartilage is clearly associated with macroscopic and microscopic
cartilage lesion severity. BSP may be an important factor in cartilage
degradation and its role as an angiogenesis enhancer in OA is still to be
demonstrated.
216
COMMON AND EARLY CARTILAGE DEGENERATION PATTERNS IN
AGING AND OSTEOARTHRITIC HUMAN KNEES
C. Pauli1, S. Duffy1, S. Grogan2, A. Hasegawa1, M.K. Lotz1, D.D. D’Lima2.
1The Scripps Res. Inst., La Jolla, CA, USA; 2Scripps Hlth., La Jolla, CA, USA
Purpose: A better understanding of early tissue degeneration patterns
in the aging knee can help to ﬁnd new targets for osteoarthritis (OA)
prevention and treatment. The objective of this study was to identify
common and early morphologic patterns of cartilage degeneration during
human joint aging, and to establish their correlation with changes in
anterior cruciate ligament (ACL), meniscus, and synovium.
Methods: 130 human knees (67 donors, age range 23–96), obtained
from tissue banks, were divided into eight age groups: 21–30 (n =8),
31–40 (n =6), 41–50 (n =18), 51–60 (n =21), 61–70 (n =22), 71–80
(n =20), 81–90 (n =26) and >91 (n =9). All cartilage compartments were
macroscopically assessed according to the ICRS mapping system by using
a modiﬁed Outerbridge grading system. Menisci and ACL were evaluated
macroscopically and by histopathology. Synovium histopathology was
assessed using a modiﬁed Krenn grading system for chronic synovitis.
Osteophytosis was macroscopically assessed.
Results: We found a strong correlation between cartilage, meniscus,
and ACL degeneration with aging. The earliest cartilage lesions were
detected in the central area of the lateral tibial plateau that is not
covered by the meniscus, followed by changes in patella and trochlea.
Degeneration in the medial femoral condyle appeared later than in
the tibia plateau but progressed rapidly to become the most severely
affected among all articular surfaces. On the other hand, degeneration
in the lateral femoral condyle progressed less rapidly in all age groups.
In the lateral TFJ, more knees had a higher tibial than femoral average
grade at all ages. This pattern was similar but reversed with aging in the
medial TFJ. Degeneration of the meniscus-covered tibia surface correlated
with increased meniscus degeneration. A common macroscopic pattern
(33%) was degeneration in tibia and meniscus with a normal-appearing
femoral condyle. In 14% we found degenerative changes in the tibia
while menisci and femoral condyles were normal. In 18% we found
a macroscopically normal meniscus while there were degenerative
changes in tibia (uncovered portion) and femoral condyle. ACL scores
increase with cartilage degeneration at all stages of OA development and
correlated with cartilage as well as meniscus degeneration, especially
in the medial compartment. Moderate and severe OA groups showed
signiﬁcantly higher ACL substance scores than the minimal/mild OA
groups. Synovitis correlated with cartilage degeneration and the presence
of osteophytes. In our donor population every knee with osteophytes was
accompanied by synovitis.
Conclusions: By examining younger age groups, we were able to
identify early patterns of cartilage degeneration. Our data suggest that
in younger subjects the lateral tibia plateau shows the earliest and
most severe degeneration. Contrary to the notion that the medial
TFJ compartment in severe OA is most affected, we found that the
lateral tibia plateau is affected the earliest. The uncovered part of the
tibia plateau degenerated ﬁrst, followed by early surface degeneration
in the inner rim of the menisci. Degeneration of the covered tibia
region increased with cumulative meniscus degeneration, supporting
the protective role of menisci. This cross-sectional study emphasizes the
importance of interaction of the different joint tissues in OA initiation
and progression and deﬁnes speciﬁc regions in the joint for future studies
on biomechanical and cellular factors that determine early stages of OA
initiation to reveal novel targets for preventing or delaying OA.
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COMPARISON OF SYNOVIAL FLUID ARGS CONCENTRATIONS AT
BASELINE AND ONE-YEAR POST-ACL RECONSTRUCTION COMPARED
TO HEALTHY, MATCHED CONTROLS
T.W. Tourville1, R.J. Johnson1, S. Naud1, J.R. Slauterbeck1, A. Struglics2,
S. Lohmander2, B.D. Beynnon1. 1Univ. of Vermont, Burlington, VT, USA;
2Lund Univ., Lund, Sweden
Purpose: The clinical signs and symptoms of post-traumatic
osteoarthritis (PTOA) following severe joint injury, such as that associated
with anterior cruciate ligament (ACL) tears, typically present 10–20 years
